Loading...

NewAmsterdam Pharma Company N.V.

NAMSW•NASDAQ
Healthcare
Biotechnology
$28.00
$5.20(22.81%)
U.S. Market opens in 53h 58m

NewAmsterdam Pharma Company N.V. (NAMSW) Stock Overview

Explore NewAmsterdam Pharma Company N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.2B
P/E Ratio-22.09
EPS (TTM)N/A
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$21.86
3 Months$22.71
1 Year Target$28.46

NAMSW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NewAmsterdam Pharma Company N.V. (NAMSW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.36, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $28.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.09 and a market capitalization of 3.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
22.63%
5-Day Change
31.70%
1-Month Change
24.27%
3-Month Change
37.67%
6-Month Change
3.59%
Year-to-Date (YTD) Change
21.57%
1-Year Change
190.95%
3-Year Change
1069.87%
5-Year Change
2627.80%
All-Time (Max) Change
996.47%

Contact Information

https://www.newamsterdampharma.com
31 35 206 2971
Gooimeer 2-35, Naarden, NaN, 1411 DC

Company Facts

680 Employees
IPO DateFeb 10, 2021
CountryNL
Actively Trading

Frequently Asked Questions